Magnetoliposomes: recent advances in the field of controlled drug delivery
- PMID: 33836636
- DOI: 10.1080/17425247.2021.1915983
Magnetoliposomes: recent advances in the field of controlled drug delivery
Abstract
Introduction: Magnetoliposomes have gained increasing attention as delivery systems, as they surpass many limitations associated with liposomes. The combination with magnetic nanoparticles provides a means for development of multimodal and multifunctional theranostic agents that enable on-demand drug release and real-time monitoring of therapy.
Areas covered: Recently, several magnetoliposome structures have been reported to ensure efficient transport and delivery of therapeutics, while improving magnetic properties. Besides, novel techniques have been introduced to improve on-demand release, as well as to achieve sequential release of different therapeutic agents. This review presents the major types and methods of preparation of magnetoliposomes, and discusses recent strategies in the trigger of drug release, development of theranostic formulations, and delivery of drugs and biological entities.
Expert opinion: Despite significant advances in efficient drug delivery, current literature lacks an assessment of formulations as theranostic agents and complementary techniques to optimize thermotherapy efficiency. Plasmonic magnetoliposomes are highly promising multimodal and multifunctional systems, providing the required design versatility to optimize theranostic capabilities. Further, photodynamic therapy and delivery of proteins/genes can be improved with a deeper research on the employed magnetic material and associated toxicity. A scale-up procedure is also lacking in recent research, which is limiting their translation to clinical use.
Keywords: Magnetic nanoparticles; cancer therapy; drug delivery; liposomes; magnetic hyperthermia; magnetoliposomes; photothermia; theranostics.
Similar articles
-
Thermosensitive gemcitabine-magnetoliposomes for combined hyperthermia and chemotherapy.Nanotechnology. 2016 Feb 26;27(8):085105. doi: 10.1088/0957-4484/27/8/085105. Epub 2016 Jan 28. Nanotechnology. 2016. PMID: 26820520
-
Combined Magnetoliposome Formation and Drug Loading in One Step for Efficient Alternating Current-Magnetic Field Remote-Controlled Drug Release.ACS Appl Mater Interfaces. 2020 Jan 29;12(4):4295-4307. doi: 10.1021/acsami.9b20603. Epub 2020 Jan 15. ACS Appl Mater Interfaces. 2020. PMID: 31904927
-
Stealth Magnetoliposomes Based on Calcium-Substituted Magnesium Ferrite Nanoparticles for Curcumin Transport and Release.Int J Mol Sci. 2020 May 21;21(10):3641. doi: 10.3390/ijms21103641. Int J Mol Sci. 2020. PMID: 32455630 Free PMC article.
-
Magnetoliposomes in Controlled-Release Drug Delivery Systems.Crit Rev Biomed Eng. 2019;47(6):495-505. doi: 10.1615/CritRevBiomedEng.2020033002. Crit Rev Biomed Eng. 2019. PMID: 32421974 Free PMC article. Review.
-
The Therapeutic Potential of Chemo/Thermotherapy with Magnetoliposomes for Cancer Treatment.Pharmaceutics. 2022 Nov 11;14(11):2443. doi: 10.3390/pharmaceutics14112443. Pharmaceutics. 2022. PMID: 36432634 Free PMC article. Review.
Cited by
-
The landscape of CRISPR/Cas9 for inborn errors of metabolism.Mol Genet Metab. 2023 Jan;138(1):106968. doi: 10.1016/j.ymgme.2022.106968. Epub 2022 Dec 7. Mol Genet Metab. 2023. PMID: 36525790 Free PMC article. Review.
-
Advances in smart delivery of magnetic field-targeted drugs in cardiovascular diseases.Drug Deliv. 2023 Dec;30(1):2256495. doi: 10.1080/10717544.2023.2256495. Drug Deliv. 2023. PMID: 37702067 Free PMC article. Review.
-
Hybrid Magnetic Lipid-Based Nanoparticles for Cancer Therapy.Pharmaceutics. 2023 Feb 23;15(3):751. doi: 10.3390/pharmaceutics15030751. Pharmaceutics. 2023. PMID: 36986612 Free PMC article. Review.
-
Doxorubicin Loaded Thermosensitive Magneto-Liposomes Obtained by a Gel Hydration Technique: Characterization and In Vitro Magneto-Chemotherapeutic Effect Assessment.Pharmaceutics. 2022 Nov 18;14(11):2501. doi: 10.3390/pharmaceutics14112501. Pharmaceutics. 2022. PMID: 36432692 Free PMC article.
-
Computational Modeling of Combination of Magnetic Hyperthermia and Temperature-Sensitive Liposome for Controlled Drug Release in Solid Tumor.Pharmaceutics. 2021 Dec 24;14(1):35. doi: 10.3390/pharmaceutics14010035. Pharmaceutics. 2021. PMID: 35056931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources